Biological Safety Cabinates Market Trends and Forecast up to 2025

Biological safety cabinets, are enclosed ventilated workstations that facilitate safe handling of biological samples, contaminants, and other potentially hazardous materials from exposure to biohazards and cross contamination during laboratory procedures. These are also referred to as biosafety cabinets or microbiological safety cabinets. The primary purpose of these biological safety cabinets is to provide protection to personnel, products, and working environment from biological containments and other hazardous material contained within and surrounding the cabinets. Biological safety cabinets are designed to provide different levels of protection in order to obtain optimum control over product quality by reducing potential risk of exposure to biohazards materials. There are three different classes of biological safety cabinets in the market based on the need for specific application and level of bio-containment required. Increasing number of clinical research organizations due to upsurge in R&D activities in last decade and increasing pressures of minimizing level of contamination and errors are anticipated to drive the market for global biological safety cabinets.

Obtain Report Details: http://www.transparencymarketresearch.com/biological-safety-cabinates-market.html

Biological safety cabinets are widely used by R&D organizations, scientific laboratories, and medical and clinical research institutes and related organizations. The global biological safety cabinets market is estimated to expand due to increased R&D budget by governments as well as commercial players for new product development and to serve the unmet needs in the medical and healthcare sector. The increase in R&D budgets is likely to create new opportunities for the establishment of new research labs and expansion of existing facilities, which is anticipated to increase the demand for biological safety cabinets. Current trends of laboratory automation for sample preparation, storage, and movement of samples and related products has improved the work efficiency with less human errors and minimized levels of contamination. Technological advancements in development of automated biological safety cabinets provides the integration of laboratory accessories and other instruments, which minimizes the need for human manipulations and improves product as well as personnel safety. Moreover, key factors that are likely for propel the global biological safety cabinets market are increasing demand for laboratory automation processes and integration of lab services with enhanced product quality. However the high cost of biological safety cabinets, safety issues, and lack of skilled professionals for operating and maintaining biological safety cabinets are estimated to hinder the expansion of the market during the forecast period.

The global biological safety cabinet can be segmented into type of biological safety cabinet, end-user, and geography. In terms of type of biological safety cabinet, the market can be segmented into Class I, Class II, and Class III safety cabinets. These cabinets are provided with high efficiency particulate air filters in their exhaust and or supply systems. Class I cabinets provide protection to personnel and environment and not to products and sample. Class II biological safety cabinets are further classified into type A1, type A2 and type B1, type B2. Class III cabinets are gas-tight enclosures with non-opening view window designed to work with high risk biological agents and provide maximum protection for environment and personnel. In terms of end-user, the biological safety cabinets market can be segmented into clinical and contract research organizations, pharmaceutical and biotechnological companies, educational institutions, and general healthcare institutions.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26882

In terms of geography, the global biological safety cabinets market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global biological safety cabinets market due to advanced healthcare infrastructure and availability of skilled professionals in the region. It is projected to maintain its dominance during the forecast period. Europe follows North America in terms of market share in the global market. The European Union (EU) has set a target of raising R&D investments to 3 % of GDP by 2020. Asia Pacific is projected to expand at a significant CAGR during the forecast period due to increased R&D expenditure by the governments and commercial players in the region. According to the UNESCO Institute for Statistics’ new data tool, China has increased its R&D budget by 18.03 % over 2015. The increased R&D budgets by India, China, South Korea, & Japan are likely to drive the growth of this market during the forecast period.

Key players operating in the global biological safety cabinets market include Germfree Laboratories, Inc., NuAire, Thermo Fisher Scientific Inc., Erlab DFS, Esco Micro Pte Ltd., MRC ltd., Labconco Corporation, The Baker Company, Kewaunee Scientific Corporation, and BIOBASE Group. Companies are focusing on development of automated biological safety cabinets to enhance work flow efficiency and minimize human errors.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Blood Viscometer Market Outlook Key Analysis and Forecast by 2025

The measurement of the viscosity of blood is done by using a blood viscometer. Rheometer measures the viscosity of a fluid with various flow conditions, whereas, viscometers measure the viscosity with one flow condition. The applications of the blood viscometer are to diagnose the viscosity of the blood which is helpful in diagnosis of all known risk factors related to cardiovascular diseases, which include high blood cholesterol, pressure, smoking, diabetes and other cardiovascular diseases. This helps predict cardiovascular diseases, and ultimately, the viscosity of the blood can be improved with the help of the medication from experts. Not only the blood viscometer helps in the prediction of cardiovascular diseases but also, other major diseases such as Alzheimer’s disease, migraines, diabetes, gout, and rheumatoid arthritis.

Obtain Report Details: http://www.transparencymarketresearch.com/blood-viscometer-market.html

Viscosity can be determined over a wide range of shear stresses, as infrared sensors are incorporated in the new capillary blood viscometer. The blood viscometer is designed in such a way that the blood flows through the capillary and the flow of the blood varies according to the time. In the blood viscometer there is an air chamber which has a suitable transducer to measure the pressure and the pressure varies according to the time. The blood flows through a compliant membrane to the sample in a fixed volume air chamber due to pressure. In the capillary, the air pressure controls the instantaneous shear stress of the blood, whereas pressure, which is time derivative, controls the instantaneous shear rate. Nonlinear sample viscosity determines the entire blood flow resistance. The air chamber comprises two parts, which can be disconnected from each other. This allows the easy discard of the blood containing part of the instrument, eliminating the cleaning and handling of blood-contacted components. There is no need of anticoagulants, as the entire process is completed within a minute.

The driving forces of the market for blood viscometer include simplicity in usage, requirement of one run and small test sample volume, short measuring time, viscosity can be measured over a range of shear rates, and the non-requirement of anticoagulants. The advancements and developments in research of the blood viscometer have led to overcoming of the challenges posed by the traditional viscometer or rheometer methods. This, in turn, has led to the significant demand for these devices, thereby driving the market for the blood viscometer. Rising threat of various cardiovascular diseases, Alzheimer’s disease, migraines, diabetes, gout, and rheumatoid arthritis has greatly increased the demand for blood viscometers across the globe. However, the advancements in the research and development of other methods of prediction of cardiovascular diseases and other diseases have proven to be restraints for the blood viscometer market.

In terms of product type, the global blood viscometer market can be segmented into rotational viscometer, capillary viscometer, and other instruments. In terms of end-user, the blood viscometer market can be segmented into clinics, hospitals, laboratories, and others.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26885

Geographically, the global blood viscometer market can be segmented into North America, Latin America, Europe, Asia Pacific, & Middle East & Africa. North America dominates the global blood viscometer market in 2016, as there are significant investments in research and development of blood viscometers which has led to production of the advanced and developed blood viscometers resulting in whooping considerable demand for blood viscometer products in the region. The market in Asia Pacific is estimated to expand due to the population pool especially in countries like India and China, and spreading awareness about the blood viscometer’s wide applications.

Key players operating in the blood viscometer market include Thermo Fisher Scientific, Anton Paar, RheoSense, Brookfield, BioFluid Technology, Health Onvector, Lamy rheology, Lauda, Benson Viscometer, and HRD.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Therapeutic Hypothermia Systems Market: Impact of Key Factors Influencing the Parent Industry

Therapeutic hypothermia, also known as targeted temperature management or protective hypothermia, is reduction of body temperature, from 32 °C to 34 °C for faster recovery. Therapeutic hypothermia is crucial in the treatment of cardiovascular conditions cardiac arrests and myocardial infarction. Therapeutic hypothermia improves neurological functioning after resuscitation from cardiac arrest. This stabilizes calcium and glutamate levels in the brain cells leading to reduction in cell death. Hence, reduction of body temperature during a surgery is said to increase chances of survival in patients.

Obtain Report Details: http://www.transparencymarketresearch.com/therapeutic-hypothermia-systems-market.html

The global therapeutic hypothermia systems market is anticipated to expand at a significant growth rate in the next few years. Rise in prevalence of cardiovascular diseases is one of the major factors fueling the growth of the global therapeutic hypothermia systems market. According to the American Heart Association, cardiovascular disease account for 2,200 deaths in the U.S. each day. This is likely to drive the global therapeutic hypothermia systems market during the forecast period. Rise in surgeries, prevalence of unhealthy lifestyle, increasing prevalence of neurological conditions, and growing geriatric population are the factors boosting the growth of the global therapeutic hypothermia systems market. Technological advancements leading to higher penetration of devices in many regions are propelling the growth of the global market during the forecast period. Unfavorable regulatory reforms in the U.S., stringent regulatory policies, and high price of the systems are factors expected to restrain the global therapeutic hypothermia market from 2017 to 2025.

The global therapeutic hypothermia systems market can be segmented based on technique, device type, application, end-user, and region. In terms of technique, the market can be categorized into non-invasive and invasive. Based on device type, the global therapeutic hypothermia systems market can be segmented into cooling catheters, water blankets, cool caps, and others. In terms of application, the market can segmented into neurology, cardiology, neonatal care, orthopedics, and others. The cardiology segment is projected to account for the largest market share owing to high prevalence of cardiovascular conditions. Based on end-user, the global market can be categorized into hospitals, emergency units, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest share in terms of revenue due to growing preference of patients for hospitals than other healthcare providers’ world over.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=27023

Geographically, the global therapeutic hypothermia systems market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global therapeutic hypothermia systems market in terms of both revenue and volume. Higher penetration rate, increase in health care expenditure, developed health care infrastructure, and prevalence of unhealthy lifestyle are the major factors likely to drive the therapeutic hypothermia systems market in the region during the forecast period. Asia Pacific is expected to be the fastest growing market for therapeutic hypothermia systems during the forecast period due to factors such as developing health care infrastructure, government initiatives, prevalence of unhealthy lifestyle, and technological advancements.

Key players in the global therapeutic hypothermia systems market are MTRE Advanced Technologies Ltd., EMCOOLS Medical Cooling Systems GmbH, Koninklijke Philips N.V., and C. R. Bard, Inc., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Nootropic Products Market Offering High-growth Opportunities for Market Players

Nootropic Products Market: Overview

The term Nootropic is derived from Greek word noos and tropein which means mind and towards respectively. In general Nootropic products are natural and synthetic compounds that can enhance memory, alertness, attention and other cognitive abilities. Nootropic products are alternatively coined as cognitive enhancers and brain boosters for their ability to produce positive effects on brain performances. Nootropic products are gaining a lot of acceptance in recent years as mood enhancers due to growing prevalence of depression and mental fatigue among youths across the globe.

Nootropic Products Market: Trends and Developments

Nootropic products are a newly emerging category of supplements called as smart drugs aimed at enhancing brain functions and performances. Many students and researches are not only experimenting on the efficacy of the drugs and its probable side effects but are also using some of the approved products such as Modafinil which by 2013 is unfortunately the only available product by prescription. However, there are varieties of other products which can be obtained as supplements without any prescription. These include CDPCholine, Piracetam and either pyritinol or sulbutiamine just to begin with.

Obtain Report Details: http://www.transparencymarketresearch.com/nootropic-products-market.html

Some of the other commonly and widely used nootropic products in 2014 encompass Noopept, Pramiracetam, Modafinil, Adrafinil, Aniracetam and Phenylpiracetam among others. Noopept is one of the long considered supplements primarily used to gain number of effective benefits related to synaptic plasticity. Other benefits of Noopept include improved reflexes, mood enhancer, improved logical thinking and controlled anxiety level. This supplement works by stimulating NDMA and APMA receptor sites within the brain that improve the activity of neurotransmitters such as Dopamine, Serotonin and Glutamate among others.

Modafinil on the other hand by now the strongest nootropic and must be used with caution. Though it was originally developed for clinical trials for narcolepsy and other sleep defects but has gain acceptance in sleep apnea treatment and professionals such as doctors, nurses and call center employees to gain mental alertness and active neural responses and as mentioned above it is a prescription only drug and cannot be availed over the counter in many parts of the world.
For people in regions such as the United States where Modafinil cannot be availed directly, Adrafinil is the strongest alternative as it is converted into Modafinil in liver and is legal to purchase. It is generally advised to use Adrafinil either on a cycle or occasional basis to avoid tolerance build-up. A survey by the University of Cambridge paper, found that 10 per cent of students take Modafinil or other similar drugs to improve their ability to concentrate during exams.

Nootropic Products Market: Drivers and Trends

Some of the prominent drivers for these medicines or supplements in forthcoming years include intensive research with various natural as well as synthetic Nootropic products for curing diseases such as Alzheimer’s, dementia, attention deficit hyperactivity disorder, Parkinson’s diseases and even age-related cognitive disorders. With increasing population of depression, mood and emotional disorders across globe will positively enhance the acceptance and upliftment of nootropic products in near future.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12233

The lack of proper treatment and hesitation to visit neurologist or psychiatrist in emerging and other developing nations are major concern and restraints to this market. Lack of awareness and product knowledge as supplements is affecting the present market by a significantly. Collaboration with government organizations and other corporate and nonprofit agencies for creating awareness and treatment centers for diseases or other memory related and mental alertness issues will create a lucrative opportunities for existing and new nootropic products market.

Some of the key players in the global Nootropic products market include Cephalon, Inc., United Pharmacies (UK), Purelife Bioscience Co., Ltd among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Additional Defibrillator Accessories Market is Expected to Witness Dynamic Growth in Future!!

Defibrillation is a treatment procedure used during life threatening conditions that affect the rhythm of the heart such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The treatment includes an electric shock given to the heart which results into depolarization of the heart muscles, leading to normal conduction of heart’s electrical impulse. Defibrillator is a device used in this treatment to deliver an electric shock to the heart. It is an important medical device used during cardiopulmonary resuscitation (CPR). Defibrillation is indicated in certain types of cardiac dysrhythmias such as ventricular fibrillation (VF) and pulseless ventricular tachycardia. Defibrillation is not indicated when heart has completely stopped functioning as in asystole or pulseless electrical activity (PEA). Defibrillation needs to be given with proper care as incorrectly given electrical shocks can lead to dangerous dysrhythmias, such as ventricular fibrillation.

Obtain Report Details: http://www.transparencymarketresearch.com/additional-defibrillator-accessories-market.html

The global additional defibrillator accessories market is driven by rising adoption of advanced defibrillator devices in cardiac centers and hospitals. Rapid growth in elderly population with high risk of cardiac diseases, rising initiatives from private and public organizations for public access defibrillation, and increasing prevalence of heart diseases are the major drivers of the additional defibrillator accessories market. Technological advancement and initiatives by key players to develop innovative and cost effective defibrillators and accessories are driving the global additional defibrillator accessories market. Growing awareness about lifesaving potential of defibrillator has created significant demand for defibrillators and accessories. However, high cost of defibrillator devices acts as a major restraint of the market.

The global additional defibrillator accessories market has been categorized based on product type, defibrillator type, end-user, and region. In terms of product, the global market has been segmented into pads, case, battery, wall cabinets, and others. Pads are sub-segmented into adult pads and pediatric pads. Defibrillator pads have expiration dates. AED pads do not last indefinitely and should be frequently checked and changed so that it can be used during emergency cardiac arrest. Battery is another important defibrillator accessory that comes with five-year backup and is also available with long life battery of seven years. Cabinets are used in case the defibrillator needs to be mounted on a wall. These are available with and without alarm. Cases are required for soft carrying of defibrillator device. The other products include tool kits, signage, and response kits.

Based on defibrillator type, the additional defibrillator accessories market has been segmented into external defibrillators and internal defibrillators. The external defibrillators segment has been sub-segmented into manual external defibrillators and automated external defibrillators. The internal defibrillators segment has been sub-segmented into implanted defibrillators and transvenous defibrillators. In terms of end-user, the market has been segmented into hospitals and clinics, public access market, ambulatory surgical centers, home care, and others. The hospitals and clinics (cardiac centers) segment is likely to account for the largest market share.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26837

Geographically, the global additional defibrillator accessories market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the additional defibrillator accessories market. Rising prevalence of cardiovascular diseases, high incidence of cardiac arrest, increasing demand for quality health care are driving the market in North America. Asia Pacific represents the fastest-growing market owing to rising incidence of sudden cardiac arrest, increasing demand for defibrillators, high prevalence of heart diseases, and initiatives by key players on technological development of advanced cost effective defibrillators and accessories. Awareness programs regarding cardiac arrest and usage of advanced defibrillator devices is anticipated to boost the additional defibrillator accessories market in emerging countries of Asia Pacific.

Key players in the global additional defibrillator accessories market are ZOLL Medical Corporation, Cardiac Science Corporation, Defibtech, LLC., Physio-Control, Inc. (Medtronic), Koninklijke Philips N.V., and Heartshine Technologies, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Uveal Melanoma Market size and key trends in terms of volume and value 2016-2024

Global Uveal Melanom Market: Overview

Uvea is present posterior to sclera and the cornea and has three parts namely, iris, ciliary body and choroid. Uveal melanoma is referred as the cancer of the parts of eye including the iris choroid and ciliray body. It is the condition in which the tumors arise from the melanocytes residing within the uva responsible for the color of the eye. Though is a rare condition, it is most common type of intraocular malignancy in adults. The uveal melanoma treatment depends on various factors most important being the size of the tumor. This type of melanoma is completely asymptomatic in the initial stages. On enlargement of tumor with time, certain changes may be observed such as distortion of pupil, decreased visibility due to secondary retinal detachment and blurred vision. Risk factors for this kind of cancer include fair complexion, blue, and green or light colored eyes, and older age. The role of inherited genetic mutation in uveal melanoma is yet unknown. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. The society also reports about 2,730 new cases in 2014 of uveal melanoma in the U.S.

Obtain Report Details: http://www.transparencymarketresearch.com/uveal-melanoma-market.html

Global Uveal Melanom Market: Segment Outlook

The global uveal melanoma market can be segmented based on diagnostic tests, therapy type, location type and geography. Location type can be further classified as iris melanoma, choroid melanoma and ciliary melanoma. Primary treatment involves enucleation i.e. removal of the affected eye. However this has now been replaced by radiation therapies such as plaque brachytherapy in the developed countries. Other types of treatment include external beam proton therapy, transpupillary thermotherapy, surgical resection techniques (transretinal endoresection and trans-scleral partial choroidectomy), gamma knife stereotactic surgery and also combination of these modalities. For small size tumors, the treatment available includes photocoagulation, photodynamic therapy, and local resection. The selection of appropriate treatment largely depends on the size and location of the tumor; associated ocular findings; the status of the fellow eye; and individual factors, including age, life expectancy, quality of life issues, concurrent systemic diseases and patient expectations.
Diagnosis of uveal melanoma consists of careful examination of the eye by an experienced clinician. Clinical manifestations include tumor thickness more than 2 mm, sub retinal fluid, and orange pigment on the tumor surface. Various ancillary diagnostic tests include ultrasonography, high resolution ultrasound biomicroscopy, indocyanine green angiography, fluorescein angiography and oclular coherence tomography. Eye exams include ophthalmoscopy, slit-lamp biomicrocopy and gonioscopy. Eye examination is carried out by dilation of pupil with the help of medicated drops allowing doctors to visualize the parts of eye clearly through lens. Biopsy is a rarely used diagnostic test for intraocular melanoma. Regular eye examinations by an ophthalmologist are the best way to find uveal melanoma early, when chances for successful treatment are the highest.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17333

Global Uveal Melanom Market: Trends

The treatment for such metastasis disease is continuously demanding more research to determine the most effective, and life saving treatments. Extensive research is being carried out in areas of immunotherapy and targeted therapy. Ipilimumab is one such example of immunotherapy shown to help people with advanced melanoma to boost the overall immunity; however its benefits are still under clinical trials for eye melanoma. Other similar drugs under investigation include nivolumab and lambrolizumab. Selumetinib is an example of targeted drug known to slow down the growth of eye melanoma. Other targeted drugs under investigation include vemurafenib, dabrafenib and trametinib amongst various others. Astra Zeneca plc, Eli Lilly & Co., Pfizer, Inc. Novartis AG, and Spectrum Pharmaceuticals, Inc., are few key players contributing to the global uveal melanoma market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Obsessive-Compulsive Disorder Market is Expected to Witness Highest Growth During 2016 - 2024

Global Obsessive Compulsive Disorder Market: Overview

Obsessive-compulsive disorder (OCD) may be defined as an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears that lead an individual to perform repetitive behaviors. Obsessive-compulsive disorder compels a person to get stuck on a particular thought or fear. For example, a person afraid of contamination may wash his/her hands repetitively in an order to make sure his/her hands are clean. Likewise, a person may check a gas stove multiple times to be sure that it’s really turned off. Usually people affected with obsessive-compulsive disorder possess both obsessions as well as compulsions; however, in many cases individuals may have either obsessions or compulsions.

Some common thoughts that usually pop up in mind of people with obsessive-compulsive disorder are fear of being contaminated by germs or dirt, excessive thinking about religious or moral ideas, superstitions, having things orderly or symmetrical, doubts that stove is turned off and thoughts of hurting oneself or others. These thoughts cause people with obsessive-compulsive disorder to perform actions like repeatedly checking of things such as locks and switches; repeatedly reciting certain words with intent to reduce anxiety, ordering or arranging things and accumulating wastes like newspaper, wine bottles or empty food containers. The exact causes of OCD are not known, however, some possible reasons may include differences in brain structure and genetic factors.

Obtain Report Details: http://www.transparencymarketresearch.com/obsessive-compulsive-disorder-therapeutics-market.html

The treatment involves psychotherapy as well as medication. Cognitive behavior therapy (CBT) is a specific type of psychotherapy that has been useful in treating people with OCD. Cognitive behavior therapy (CBT) teaches a person multiple ways of thinking, reacting and handling a particular situation. Most commonly used medications for treating OCD include antidepressants and anti-anxiety medications. A child suffering from PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) is prescribed antibiotics for treating strep infections and SSRI medicines (citalopram, escitalopram, fluoxetine, sertraline and paroxetine).

Global Obsessive Compulsive Disorder Market: Trends

The market for obsessive-compulsive disorder (OCD) is expected to grow globally under the influence of high prevalence of OCD and life style changes causing changes in thinking processes. According to International OCD Foundation, approximately 2-3 million adults are living with OCD in the United States. The International OCD Foundation also states that nearly 500,000 American children have OCD. A large number of cases of OCD go unreported as many people are not aware that there is any such specific disease. Also, many people hide their illness in order to avoid embarrassment.

Global Obsessive Compulsive Disorder Market: Regional Outlook

Geographically, the market for obsessive-compulsive disorder (OCD) has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the largest regional market in 2013, followed by Europe, Asia-Pacific and Rest of the World (RoW). One of the major factors responsible for North America’s leading position in this particular market is well established health coverage in the region and high level of awareness regarding the illness. In Asia-Pacific and Rest of the World (RoW) regions, the market is expected to grow in coming future owing rise in prevalence of people with OCD and increasing wareness regarding the disease. Japan, China, India, Australia and New Zealand are the most potential markets in the Asia-Pacific region.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14720

Global Obsessive Compulsive Disorder Market: Key Players

Some major companies and research institutions that are extensively engaged in the development, manufacturing and marketing of OCD drugs include Abbott Laboratories, Pfizer Ltd., Merck & Co., Sanofi, Novartis AG, University of South Florida, Ortho-McNeil Janssen Scientific Affairs, LLC and Indiana University.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.